The significance of epicardial adipose tissue in different phenotypes and stages of heart failure

    Authors

    Keywords

    heart failure with preserved ejection fraction, heart failure with reduced ejection fraction, epicardial adpose tissue, prognosis

    DOI

    https://doi.org/10.15836/ccar2024.437

    Full Text

    **Goal:** To systematically investigate the role of epicardial adipose tissue (EAT) in heart failure (HF) according to key clinical data and to assess the applicability of available data in routine work. **Material and Methods:** conducted search of all relevant scientific databases to identify and analyze relevant information that were published on the highlighted topic during the past 5 years. **Results:** The evaluation of all available data analyzing the impact of echocardiographic EAT on the clinical course and prognosis HF with special emphasis on the type of HF phenotype. The cardiovascular hemodynamics and patient metabolic profile were also taken into consideration if available in the current source. **Conclusion:** According to the available data, in patients with heart failure and preserved left ventricular systolic function (HFpEF), the presence of significant accumulations of EAT is associated with a less favorable circulatory / hemodynamic, but also metabolic status and affects survival. Conversely, lower amounts of EAT are associated with an increased risk of adverse outcomes in patients with heart failure and reduced left ventricular systolic function (HFrEF). Although the causes of these facts are still at the level of pathophysiological hypotheses and require further research, the protective and good prognostic value of EAT in HFrEF, which represents the opposite clinical meaning in patients with HFpEF, are a significant contribution to the knowledge of modern science on HF that have a direct impact on clinical practice (1, 2).

    Literature

    1. Pugliese NR, Paneni F, Mazzola M, De Biase N, Del Punta L, Gargani L, et al. Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure. Eur J Heart Fail. 2021 November;23(11):1858–71. https://doi.org/10.1002/ejhf.2337
    2. Koepp KE, Obokata M, Reddy YNV, Olson TP, Borlaug BA. Hemodynamic and Functional Impact of Epicardial Adipose Tissue in Heart Failure With Preserved Ejection Fraction. JACC Heart Fail. 2020 August;8(8):657–66. https://doi.org/10.1016/j.jchf.2020.04.016
    Cardiologia Croatica
    Back to search

    The significance of epicardial adipose tissue in different phenotypes and stages of heart failure

    Extended Abstract
    Issue11-12
    Published
    Pages437
    PDF via DOIhttps://doi.org/10.15836/ccar2024.437
    heart failure with preserved ejection fraction
    heart failure with reduced ejection fraction
    epicardial adpose tissue
    prognosis

    Authors

    Koraljka BenkoORCIDUniversity Hospital Centre Rijeka, Rijeka, Croatia
    Alen Ružić*ORCIDUniversity Hospital Centre Rijeka, Rijeka, Croatia

    *Correspondence email: alen.ruzic@uniri.hr

    Full Text

    Goal: To systematically investigate the role of epicardial adipose tissue (EAT) in heart failure (HF) according to key clinical data and to assess the applicability of available data in routine work.

    Material and Methods: conducted search of all relevant scientific databases to identify and analyze relevant information that were published on the highlighted topic during the past 5 years.

    Results: The evaluation of all available data analyzing the impact of echocardiographic EAT on the clinical course and prognosis HF with special emphasis on the type of HF phenotype. The cardiovascular hemodynamics and patient metabolic profile were also taken into consideration if available in the current source.

    Conclusion: According to the available data, in patients with heart failure and preserved left ventricular systolic function (HFpEF), the presence of significant accumulations of EAT is associated with a less favorable circulatory / hemodynamic, but also metabolic status and affects survival. Conversely, lower amounts of EAT are associated with an increased risk of adverse outcomes in patients with heart failure and reduced left ventricular systolic function (HFrEF). Although the causes of these facts are still at the level of pathophysiological hypotheses and require further research, the protective and good prognostic value of EAT in HFrEF, which represents the opposite clinical meaning in patients with HFpEF, are a significant contribution to the knowledge of modern science on HF that have a direct impact on clinical practice (1, 2).

    Literature

    1. 1.
      Pugliese NR, Paneni F, Mazzola M, De Biase N, Del Punta L, Gargani L, et al. Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure. Eur J Heart Fail. 2021 November;23(11):1858–71.DOI
    2. 2.
      Koepp KE, Obokata M, Reddy YNV, Olson TP, Borlaug BA. Hemodynamic and Functional Impact of Epicardial Adipose Tissue in Heart Failure With Preserved Ejection Fraction. JACC Heart Fail. 2020 August;8(8):657–66.DOI